About this opportunity
AI summaryThe VA National Acquisition Center seeks proposals under an unrestricted procurement to supply Ramipril capsules for the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The VA will award one contract to a responsible offeror capable of providing an uninterrupted supply across several specified dosages and bottle sizes for distribution through VA and DOD Pharmaceutical Prime Vendor Programs. All responsible sources may submit an offer, but glass bottles are not acceptable, and offerors must provide a unique NDC number and state the exact labeling drug name. The buyer intends to issue solicitation 36E79726R0034 via SAM.gov on or about November 16, 2026, with a tentative closing date of November 30, 2026, or a listed response deadline of November 23, 2026, at 2:30 pm Central Time. The contract term consists of one base year plus four pre-priced one-year option periods.
Scope of work
- RAMIPRIL 1.25MG CAP 100/BT (Estimated Annual Requirements: 2,930)
- RAMIPRIL 2.5MG CAP 100/BT (Estimated Annual Requirements: 2,498)
- RAMIPRIL 2.5MG CAP 500/BT (Estimated Annual Requirements: 1,611)
- RAMIPRIL 5MG CAP 100/BT (Estimated Annual Requirements: 6,018)
- RAMIPRIL 5MG CAP 500/BT (Estimated Annual Requirements: 2,704)
- RAMIPRIL 10MG CAP 100/BT (Estimated Annual Requirements: 15,956)
- RAMIPRIL 10MG CAP 500/BT (Estimated Annual Requirements: 4,451)
- Distribution through VA and DOD Pharmaceutical Prime Vendor Programs
Minimum qualifications
- Must be able to provide an uninterrupted source of supply for the contracted items
- Must state the exact name appearing on the label by which the drug will be supplied
- Must have a unique NDC number
- Glass bottles are not acceptable
Key dates
- Response Date/Time
- 11-23-2026 2:30pm CENTRAL TIME, CHICAGO, USA
- Solicitation electronically issued on or about
- 11/16/2026
- Tentative closing date
- 11/30/2026
How to submit
- Method
- Electronic
- Instructions
- Solicitation and amendments available for download at http://www.sam.gov; no paper copies will be available or accepted by phone request
Contract details
- Term
- one year plus four pre-priced one-year option periods
Federal notice details
- Solicitation number
- 36E79726R0034
- Agency
- Department of Veterans Affairs
- Buying office
- NAC Pharmaceuticals (36E797)
- Notice type
- Presolicitation
- Responses due
- Nov 23, 2026, 3:30 PM ET
- Posted on SAM.gov
- Oct 29, 2026
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product/service code
- 6505
- Contracting contact
- [email protected], Amber Zavala
amber.zavala@va.gov
(708) 786-5245
Source: SAM.gov. Read the official notice for the complete description and current instructions.
Incumbent and award research
No incumbent history found for this requirement. The notice does not cite a current contract, and no earlier award from this buying office matches it.
Market context
Awards in the same category (Pharmaceutical Preparation Manufacturing). This is not this requirement's award history.
Recent similar awards: Department of Veterans Affairs, NAICS 325412
| Vendor and award | Value | Ends |
|---|---|---|
| PHARMALOGIC LTD36C24126P0126 · RADIOPHARMACEUTICALS | $135.8K | Dec 31, 2030 |
| CARDINAL HEALTH 414, LLC36C24126P0009 · RADIOPHARMACEUTICALS | $70,000 | Nov 25, 2030 |
| EXELAN PHARMACEUTICALS INC36C24226N0564 · LENALIDOMIDE | $3.1M | May 31, 2029 |
| CARDINAL HEALTH 414, LLC36C26224P0890 · RADIOPHARMACEUTICALS BASE PLUS FOUR OPTION YEARS | $1.4M | Feb 28, 2029 |
| RLS (USA) INC.36C26224P0297 · RADIOPHARMACEUTICALS | $1.1M | Nov 30, 2028 |
Top vendors in this category: Department of Veterans Affairs, NAICS 325412, since Oct 1, 2024
4,151 contract awards in this NAICS over the period.
- 1. MCKESSON CORPORATION$24.6B
- 2. EXELAN PHARMACEUTICALS INC$100.2M
- 3. PROGENICS PHARMACEUTICALS INC$85.0M
- 4. CARDINAL HEALTH 414, LLC$61.3M
- 5. NOVARTIS PHARMACEUTICALS CORPORATION$55.3M
Source: USAspending.gov federal award data (U.S. federal public data). A contract is called the incumbent only when the notice or its documents cite it by number.